Scripts for cash-pay clinics: how the economics work

Landed cost in a cash-pay clinic is the per-vial drug cost plus any shipping, processing, and platform or facilitation fees. Scripts positions itself on exclusive GPO-negotiated pricing across its hand-selected pharmacy network — described as 'elite pricing' that gives pharmacy partners strong margins while keeping clinic costs competitive. Because pricing is visible in the portal after approval rather than on the public site, the clinic confirms the all-in number during onboarding. The practical questions to answer before signing are: what is the per-vial rate on your top 5 SKUs inside the portal, what shipping and processing fees sit on top, and whether the exclusive rate holds across refill cycles without renegotiation.

For a cash-pay model, predictability matters as much as the headline rate. Scripts's GPO leverage is a genuine advantage for clinics that qualify and run volume — the question is whether the portal pricing, combined with concierge support overhead, delivers better total economics than alternatives that surface pass-through per-vial cost before checkout.

Fizy Health takes a pass-through approach built for cash-pay margin. It shows resolved 503A per-vial cost on every catalog and cart line before checkout, with a disclosed facilitation fee at payment — so the owner sets patient prices on the same number the clinic will actually pay, and the prescriber can quote at the visit on live cost without being inside a portal first. There is no GPO negotiation layer separating the drug cost from what the clinic sees; the cost passes through and the fee is stated.

On the operations side, one clinic cart batches the refill day and cart validation catches invalid SIGs, prescriber state mismatches, and stock gaps before payment, so the clinic stops paying for orders that get rejected after checkout. The tradeoff is that Fizy Health does not offer 503B office-use bulk access in its current product, which Scripts does. If your cash-pay model relies on 503B bulk ordering alongside 503A patient-specific prescriptions, that is a meaningful difference to validate before choosing.